UV-Laser Microdissection and mRNA Expression Analysis of Individual Neurons from Postmortem Parkinson’s Disease Brains

Methods in Molecular Biology

Volumn 755, Issue , 2011, Pages 363-374

  Gründemann, Jan ^a   Schlaudraff, Falk ^b   Liss, Birgit ^b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF ULM   (Germany)

Author keywords

Dopamine; Human tissue; Laser microdissection; Parkinson s disease; Postmortem; Real time quantitative PCR; Reverse transcription; RNA integrity number; Single cell; Synuclein

Indexed keywords

MELANIN; MESSENGER RNA; NEUROMELANIN;

ARTICLE; BRAIN; CELL SEPARATION; CRYOPRESERVATION; GENE EXPRESSION PROFILING; GENETICS; HUMAN; INSTRUMENTATION; ISOLATION AND PURIFICATION; LASER; METABOLISM; METHODOLOGY; MICRODISSECTION; MICROTOMY; NERVE CELL; PARKINSON DISEASE; PATHOLOGY; POLYMERASE CHAIN REACTION; SINGLE CELL ANALYSIS; ULTRAVIOLET RADIATION;

BRAIN; CELL SEPARATION; CRYOPRESERVATION; GENE EXPRESSION PROFILING; HUMANS; LASERS; MELANINS; MICRODISSECTION; MICROTOMY; NEURONS; PARKINSON DISEASE; POLYMERASE CHAIN REACTION; RNA, MESSENGER; SINGLE-CELL ANALYSIS; ULTRAVIOLET RAYS;

EID: 79960965890     PISSN: 10643745     EISSN: 19406029     Source Type: Book Series    
DOI: 10.1007/978-1-61779-163-5_30     Document Type: Chapter

References (18)

1. Grundemann J, Schlaudraff F, Haeckel O et al (2008) Elevated alpha-synuclein mRNA levels in individual UV-laser-microdissected dopaminergic substantia nigra neurons in idio-pathic Parkinson’s disease. Nucleic Acids Res 36:e38
2. Simunovic F, Yi M, Wang Y et al (2009) Gene expression profiling of substantia nigra dopamine neurons: further insights into Parkinson’s disease pathology. Brain 132:1795–1809
3. Huggett J, Dheda K, Bustin S et al (2005) Real-time RT-PCR normalisation; strategies and considerations. Genes Immun 6:279–284
4. Bustin SA, Nolan T (2004) Pitfalls of quantitative real-time reverse-transcription polymerase chain reaction. J Biomol Tech 15:155–166
5. Damier P, Hirsch EC, Agid Y et al (1999) The substantia nigra of the human brain. II. Patterns of loss of dopamine-containing neurons in Parkinson’s disease. Brain 122:1437–1448
6. Damier P, Hirsch EC, Agid Y et al (1999) The substantia nigra of the human brain. I. Nigrosomes and the nigral matrix, a compartmental organization based on calbindin D(28K) immunohistochemistry. Brain 122: 1421–1436
7. Hirsch EC, Hunot S (2009) Neuroinflammation in Parkinson’s disease: a target for neuroprotec-tion?. Lancet Neurol 8:382–397
8. Dachsel JC, Lincoln SJ, Gonzalez J et al (2007) The ups and downs of alpha-synuclein mRNA expression. Mov Disord 22:293–295
9. Cookson MR (2009) alpha-Synuclein and neuronal cell death. Mol Neurodegener 4:9
10. Ramirez A, Heimbach A, Grundemann J et al (2006) Hereditary parkinsonism with dementia is caused by mutations in ATP13A2, encoding a lysosomal type 5 P-type ATPase. Nat Genet 38:1184–1191
11. Ibanez P, Bonnet AM, Debarges B et al (2004) Causal relation between alpha-synuclein gene duplication and familial Parkinson’s disease. Lancet 364:1169–1171
12. Eriksen JL, Przedborski S, Petrucelli L (2005) Gene dosage and pathogenesis of Parkinson’s disease. Trends Mol Med 11:91–96
13. Polymeropoulos MH, Lavedan C, Leroy E et al (1997) Mutation in the alpha-synuclein gene identified in families with Parkinson’s disease. Science 276:2045–2047
14. McCormack AL, Di Monte DA (2009) Enhanced alpha-synuclein expression in human neurodegenerative diseases: pathogenetic and therapeutic implications. Curr Protein Pept Sci 10:476–482
15. Simon-Sanchez J, Schulte C, Bras JM et al (2009) Genome-wide association study reveals genetic risk underlying Parkinson’s disease. Nat Genet 41:1308–1312
16. Satake W, Nakabayashi Y, Mizuta I et al (2009) Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson’s disease. Nat Genet 41:1303–1307
17. Liss B (2002) Improved quantitative real-time RT-PCR for expression profiling of individual cells. Nucleic Acids Res 30:e89
18. Liss B, Franz O, Sewing S et al (2001) Tuning pacemaker frequency of individual dopaminergic neurons by Kv4.3L and KChip3.1 transcription. EMBO J 20: 5715–5724